Annovis Bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Annovis Bio and other ETFs, options, and stocks.

About ANVS

Annovis Bio, Inc. is a clinical stage drug platform company, which engages in the development of drugs aiming to treat neurodegenerative diseases, such as Alzheimer's (AD) and Parkinson's (PD). Its lead product candidate, Buntanetap, is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. 

CEO
Maria-Luisa Maccecchini
CEOMaria-Luisa Maccecchini
Employees
8
Employees8
Headquarters
Malvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded
2008
Founded2008
Employees
8
Employees8

ANVS Key Statistics

Market cap
80.04M
Market cap80.04M
Price-Earnings ratio
-2.03
Price-Earnings ratio-2.03
Dividend yield
Dividend yield
Average volume
632.96K
Average volume632.96K
High today
$3.13
High today$3.13
Low today
$2.92
Low today$2.92
Open price
$3.02
Open price$3.02
Volume
313.50K
Volume313.50K
52 Week high
$5.50
52 Week high$5.50
52 Week low
$1.11
52 Week low$1.11

Stock Snapshot

As of today, Annovis Bio(ANVS) shares are valued at $2.95. The company's market cap stands at 80.04M, with a P/E ratio of -2.03.

As of 2026-01-24, Annovis Bio(ANVS) stock has fluctuated between $2.92 and $3.13. The current price stands at $2.95, placing the stock +1.0% above today's low and -5.7% off the high.

The Annovis Bio(ANVS)'s current trading volume is 313.5K, compared to an average daily volume of 632.96K.

In the last year, Annovis Bio(ANVS) shares hit a 52-week high of $5.50 and a 52-week low of $1.11.

In the last year, Annovis Bio(ANVS) shares hit a 52-week high of $5.50 and a 52-week low of $1.11.

People also own

Based on the portfolios of people who own ANVS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.